Hadjimichael Andreas
SEC CIK 1591256 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACRV | Acrivon Therapeutics, Inc. | 10% | 3.86M | $5.00M | — | 2 | 2022-11-17 | 2022-11-17 |
Most active insiders at ACRV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Blume-Jensen Peter | Pres, CEO, Dir | $82.3K | $34.4K |
| 2 | Devroe Eric | COO | $17.2K | $1,214 |
| 3 | Levy Adam D. | CFO | $15.0K | $1,793 |
| 4 | Miller Mary | CLO | — | $1,380 |
| 5 | Gamelin Erick | Chief Development Off | — | $804.00 |
| 6 | Peterson Katharine | CAO | — | $203.01 |
| 7 | Levin Michaela | Chief Business Off | — | — |
| 8 | Palani Santhosh | Dir | — | — |
| 9 | Masson Kristina | EVP - Business Ops, Dir | — | — |
| 10 | DiRocco Derek | Dir | — | — |
Hadjimichael Andreas made no open-market trades at ACRV in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-21 | 2022-11-17 | ACRV | Acrivon Therapeutics, Inc. | Hadjimichael Andreas | 10% | P - Purchase | $12.50 | +400.0K | 3.86M | +12% | +$5.00M |
| DM | 2022-11-21 | 2022-11-17 | ACRV | Acrivon Therapeutics, Inc. | Hadjimichael Andreas | 10% | C - Cnv Deriv | — | +3.46M | 3.86M | +864% | — |
Purchase Sale Sale after option exercise All abbreviations